Cargando…
Synthesis and biological evaluation of 2-arylbenzofuran derivatives as potential anti-Alzheimer’s disease agents
Alzheimer's disease (AD) is a type of progressive dementia caused by degeneration of the nervous system. A single target drug usually does not work well. Therefore, multi-target drugs are designed and developed so that one drug can specifically bind to multiple targets to ensure clinical effect...
Autores principales: | Yun, Yinling, Miao, Yuhang, Sun, Xiaoya, Sun, Jie, Wang, Xiaojing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765280/ https://www.ncbi.nlm.nih.gov/pubmed/34134572 http://dx.doi.org/10.1080/14756366.2021.1940993 |
Ejemplares similares
-
Synthesis and biological evaluation of 3-arylbenzofuranone derivatives as potential anti-Alzheimer’s disease agents
por: Yang, Jie, et al.
Publicado: (2020) -
Synthesis and anti-rheumatoid arthritis activities of 3-(4-aminophenyl)-coumarin derivatives
por: Miao, Yuhang, et al.
Publicado: (2021) -
Semi-synthesis, structural modification and biological evaluation of 5-arylbenzofuran neolignans
por: Lin, Ding, et al.
Publicado: (2018) -
Synthesis and biological evaluation of 3-arylcoumarins as potential anti-Alzheimer's disease agents
por: Yang, Jie, et al.
Publicado: (2019) -
Synthesis and biological evaluation of 3-arylcoumarin derivatives as potential anti-diabetic agents
por: Hu, Yuheng, et al.
Publicado: (2018)